These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 15570503)

  • 1. [No evidence for gender-specific sharing of COMT alleles in schizophrenia].
    Sand P; Störtebecker P; Langguth B; Hajak G; Eichhammer P
    Psychiatr Prax; 2004 Nov; 31 Suppl 1():S58-60. PubMed ID: 15570503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No associations exist between five functional polymorphisms in the catechol-O-methyltransferase gene and schizophrenia in a Japanese population.
    Nunokawa A; Watanabe Y; Muratake T; Kaneko N; Koizumi M; Someya T
    Neurosci Res; 2007 Jul; 58(3):291-6. PubMed ID: 17482701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of an association between the COMT polymorphism and clinical symptomatology in schizophrenia.
    Strous RD; Lapidus R; Viglin D; Kotler M; Lachman HM
    Neurosci Lett; 2006 Jan; 393(2-3):170-3. PubMed ID: 16233957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catechol-O-methyltransferase haplotypes are associated with psychosis in Alzheimer disease.
    Sweet RA; Devlin B; Pollock BG; Sukonick DL; Kastango KB; Bacanu SA; Chowdari KV; DeKosky ST; Ferrell RE
    Mol Psychiatry; 2005 Nov; 10(11):1026-36. PubMed ID: 16027741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catechol-O-methyl transferase and schizophrenia.
    Sagud M; Mück-Seler D; Mihaljević-Peles A; Vuksan-Cusa B; Zivković M; Jakovljević M; Pivac N
    Psychiatr Danub; 2010 Jun; 22(2):270-4. PubMed ID: 20562760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variation in COMT and PRODH is associated with brain anatomy in patients with schizophrenia.
    Zinkstok J; Schmitz N; van Amelsvoort T; Moeton M; Baas F; Linszen D
    Genes Brain Behav; 2008 Feb; 7(1):61-9. PubMed ID: 17504246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haplotypic association spanning the 22q11.21 genes COMT and ARVCF with schizophrenia.
    Sanders AR; Rusu I; Duan J; Vander Molen JE; Hou C; Schwab SG; Wildenauer DB; Martinez M; Gejman PV
    Mol Psychiatry; 2005 Apr; 10(4):353-65. PubMed ID: 15340358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of catechol-O-methyltransferase to schizophrenia and its correlates: evidence for associations and complex interactions.
    Lewandowski KE
    Harv Rev Psychiatry; 2007; 15(5):233-44. PubMed ID: 17924258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms in catechol-O-methyltransferase and methylenetetrahydrofolate reductase in relation to the risk of schizophrenia.
    Muntjewerff JW; Gellekink H; den Heijer M; Hoogendoorn ML; Kahn RS; Sinke RJ; Blom HJ
    Eur Neuropsychopharmacol; 2008 Feb; 18(2):99-106. PubMed ID: 17716874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The met(158) allele of catechol-O-methyltransferase (COMT) is associated with obsessive-compulsive disorder in men: case-control study and meta-analysis.
    Pooley EC; Fineberg N; Harrison PJ
    Mol Psychiatry; 2007 Jun; 12(6):556-61. PubMed ID: 17264842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Higher scores of self reported schizotypy in healthy young males carrying the COMT high activity allele.
    Avramopoulos D; Stefanis NC; Hantoumi I; Smyrnis N; Evdokimidis I; Stefanis CN
    Mol Psychiatry; 2002; 7(7):706-11. PubMed ID: 12192614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COMT gene val158met polymorphism in patients with dyspeptic symptoms.
    Tahara T; Arisawa T; Shibata T; Nakamura M; Wang F; Hirata I
    Hepatogastroenterology; 2008; 55(84):979-82. PubMed ID: 18705311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between high-activity COMT allele and alcoholism.
    Serý O; Didden W; Mikes V; Pitelová R; Znojil V; Zvolský P
    Neuro Endocrinol Lett; 2006; 27(1-2):231-5. PubMed ID: 16648777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical involvement of catechol-O-methyltransferase polymorphisms in schizophrenia spectrum disorders: influence on the severity of psychotic symptoms and on the response to neuroleptic treatment.
    Molero P; Ortuño F; Zalacain M; Patiño-García A
    Pharmacogenomics J; 2007 Dec; 7(6):418-26. PubMed ID: 17363961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catechol-O-methyltransferase gene and obsessive-compulsive symptoms in patients with recent-onset schizophrenia: preliminary results.
    Zinkstok J; van Nimwegen L; van Amelsvoort T; de Haan L; Yusuf MA; Baas F; Linszen D
    Psychiatry Res; 2008 Jan; 157(1-3):1-8. PubMed ID: 17850881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association study of NlaIII and MspI genetic polymorphisms of catechol-O-methyltransferase gene and susceptibility to schizophrenia.
    Chen CH; Lee YR; Wei FC; Koong FJ; Hwu HG; Hsiao KJ
    Biol Psychiatry; 1997 May; 41(9):985-7. PubMed ID: 9110105
    [No Abstract]   [Full Text] [Related]  

  • 17. No association found between 158 Val/Met polymorphism of the COMT gene and schizophrenia with minor physical anomalies.
    Joo EJ; Jeong SH; Ahn YM; Lee KY; Chang Yoon S; Kim EJ; Kim SU; Cho SC; Sik Kim Y
    Psychiatry Res; 2005 Sep; 136(2-3):83-91. PubMed ID: 16109444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catechol-O-methyltransferase val108/158met genotype and response to antipsychotic medication in schizophrenia.
    Illi A; Kampman O; Hänninen K; Anttila S; Mattila KM; Katila H; Rontu R; Hurme M; Lehtimäki T; Leinonen E
    Hum Psychopharmacol; 2007 Jun; 22(4):211-5. PubMed ID: 17526059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catechol-O-methyltransferase Val158Met polymorphism in relation to aggressive schizophrenia in a Korean population.
    Kim YR; Kim JH; Kim SJ; Lee D; Min SK
    Eur Neuropsychopharmacol; 2008 Nov; 18(11):820-5. PubMed ID: 18789857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association study of COMT gene Val158Met polymorphism with auditory P300 and performance on neurocognitive tests in patients with schizophrenia and their relatives.
    Golimbet V; Gritsenko I; Alfimova M; Lebedeva I; Lezheiko T; Abramova L; Kaleda V; Ebstein R
    World J Biol Psychiatry; 2006; 7(4):238-45. PubMed ID: 17071544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.